Biotoxtech Co., Ltd. (KOSDAQ:086040)
3,355.00
+105.00 (3.23%)
At close: Apr 24, 2026
Biotoxtech Market Cap
Biotoxtech has a market cap or net worth of 52.74 billion as of April 24, 2026. Its market cap has increased by 16.49% in one year.
Market Cap
52.74B
Enterprise Value
78.88B
Revenue
47.02B
Ranking
n/a
PE Ratio
45.34
Stock Price
3,355.00
Market Cap Chart
Since September 27, 2007, Biotoxtech's market cap has increased from 27.51B to 52.74B, an increase of 91.73%. That is a compound annual growth rate of 3.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 52.74B | 19.18% |
| Dec 30, 2025 | 44.25B | -15.59% |
| Dec 30, 2024 | 52.43B | -46.56% |
| Dec 28, 2023 | 98.11B | -17.65% |
| Dec 29, 2022 | 119.14B | 1.50% |
| Dec 30, 2021 | 117.38B | -47.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADBiotech | 53.33B |
| RN2 Technologies | 53.11B |
| Gencurix | 53.06B |
| Carelabs Co.,Ltd | 52.96B |
| Moadata | 52.75B |
| WOOJUNG BIO | 52.68B |
| GFC Life Science | 52.64B |
| Watos Corea | 52.47B |